|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
58,160,000 |
Market
Cap: |
5.82(B) |
Last
Volume: |
5,449,206 |
Avg
Vol: |
5,434,465 |
52
Week Range: |
$99.99 - $99.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Spector Steven W |
SVP, General Counsel & Sec |
|
2005-03-31 |
4 |
A |
$3.75 |
$2,344 |
D/D |
625 |
44,989 |
|
- |
|
Hoffman Robert |
VP, Finance & CAO |
|
2005-03-31 |
4 |
A |
$3.75 |
$1,376 |
D/D |
367 |
52,514 |
|
- |
|
Lief Jack |
President and CEO |
|
2005-03-31 |
4 |
A |
$3.75 |
$2,344 |
D/D |
625 |
547,281 |
|
- |
|
Ajit-Simh K A |
VP, Quality Systems |
|
2004-12-31 |
4 |
A |
$3.75 |
$623 |
D/D |
166 |
454 |
|
- |
|
Spector Steven W |
SVP, General Counsel & Sec |
|
2004-12-31 |
4 |
A |
$3.75 |
$1,616 |
D/D |
431 |
44,364 |
|
- |
|
Hoffman Robert |
VP, Finance & CAO |
|
2004-12-31 |
4 |
A |
$3.75 |
$476 |
D/D |
127 |
52,147 |
|
- |
|
Lief Jack |
President and CEO |
|
2004-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
546,656 |
|
- |
|
Lief Jack |
President and CEO |
|
2004-12-31 |
4 |
A |
$3.75 |
$1,961 |
D/D |
523 |
571,656 |
|
- |
|
Spector Steven W |
SVP, General Counsel & Sec |
|
2004-09-30 |
4 |
A |
$3.66 |
$1,501 |
D/D |
410 |
43,933 |
|
- |
|
Hoffman Robert |
VP, Finance & CAO |
|
2004-09-30 |
4 |
A |
$3.66 |
$549 |
D/D |
150 |
52,020 |
|
- |
|
Lief Jack |
President and CEO |
|
2004-09-30 |
4 |
A |
$3.66 |
$2,288 |
D/D |
625 |
571,133 |
|
- |
|
Ajit-Simh K A |
VP, Quality Systems |
|
2004-09-30 |
4 |
A |
$3.66 |
$626 |
D/D |
171 |
288 |
|
- |
|
Williams Joyce H |
Former VP, Drug Development |
|
2004-08-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,500) |
74,198 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-07-08 |
4 |
S |
$5.00 |
$334,000 |
I/I |
(66,800) |
994,851 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-07-07 |
4 |
S |
$5.10 |
$3,885,176 |
I/I |
(761,288) |
1,026,851 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-07-01 |
4 |
S |
$5.42 |
$514,900 |
I/I |
(95,000) |
1,395,351 |
|
- |
|
Ajit-Simh K A |
VP, Quality Systems |
|
2004-06-30 |
4 |
A |
$4.64 |
$543 |
D/D |
117 |
117 |
|
- |
|
Lief Jack |
President and CEO |
|
2004-06-30 |
4 |
A |
$4.64 |
$2,900 |
D/D |
625 |
570,508 |
|
- |
|
Maffuid Paul W |
VP, Pharmaceutical Development |
|
2004-06-30 |
4 |
A |
$4.64 |
$501 |
D/D |
108 |
16,496 |
|
- |
|
Spector Steven W |
SVP, General Counsel & Sec |
|
2004-06-30 |
4 |
A |
$4.64 |
$1,499 |
D/D |
323 |
43,523 |
|
- |
|
Hoffman Robert |
VP, Finance |
|
2004-06-30 |
4 |
A |
$4.64 |
$478 |
D/D |
103 |
51,870 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-06-29 |
4 |
S |
$5.31 |
$376,797 |
I/I |
(71,000) |
1,441,351 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-06-28 |
4 |
S |
$5.30 |
$287,010 |
I/I |
(54,000) |
1,476,351 |
|
- |
|
Bvf Inc/il |
Indirect Beneficial Owner |
|
2004-06-18 |
4 |
S |
$5.52 |
$33,114 |
I/I |
(6,000) |
1,502,351 |
|
- |
|
Bvf Investments Llc |
Direct Beneficial Owner |
|
2004-06-16 |
4 |
S |
$5.40 |
$561,600 |
I/I |
(104,000) |
1,505,351 |
|
- |
|
415 Records found
|
|
Page 15 of 17 |
|
|